These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 26235332)
1. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis. Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332 [TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy. Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724 [TBL] [Abstract][Full Text] [Related]
4. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543 [TBL] [Abstract][Full Text] [Related]
5. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes. Saito K; Kihara K Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis. Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691 [TBL] [Abstract][Full Text] [Related]
7. Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma. Ku JH; Kim M; Choi WS; Kwak C; Kim HH Int Braz J Urol; 2014; 40(6):753-62. PubMed ID: 25615244 [TBL] [Abstract][Full Text] [Related]
8. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis. Su S; Liu L; Li C; Zhang J; Li S Int J Surg; 2019 Dec; 72():146-153. PubMed ID: 31707011 [TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis. Song H; Kuang G; Zhang Z; Ma B; Jin J; Zhang Q J Cancer; 2019; 10(2):479-487. PubMed ID: 30719143 [No Abstract] [Full Text] [Related]
10. Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder. Eggers H; Seidel C; Schrader AJ; Lehmann R; Wegener G; Kuczyk MA; Steffens S Med Oncol; 2013 Dec; 30(4):705. PubMed ID: 24005810 [TBL] [Abstract][Full Text] [Related]
11. C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis. Fujiwara Y; Karol AB; Joshi H; Reford E; Izadmehr S; Doroshow DB; Galsky MD Crit Rev Oncol Hematol; 2024 May; 197():104352. PubMed ID: 38614269 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib. Beuselinck B; Vano YA; Oudard S; Wolter P; De Smet R; Depoorter L; Teghom C; Karadimou A; Zucman-Rossi J; Debruyne PR; Van Poppel H; Joniau S; Lerut E; Strijbos M; Dumez H; Paridaens R; Van Calster B; Schöffski P BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein as a biomarker for urological cancers. Saito K; Kihara K Nat Rev Urol; 2011 Oct; 8(12):659-66. PubMed ID: 22025173 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465 [TBL] [Abstract][Full Text] [Related]
15. C-reactive protein in urologic cancers. Huang J; Baum Y; Alemozaffar M; Ogan K; Harris W; Kucuk O; Master VA Mol Aspects Med; 2015 Nov; 45():28-36. PubMed ID: 25936279 [TBL] [Abstract][Full Text] [Related]
16. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study. Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093 [TBL] [Abstract][Full Text] [Related]
17. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer. Omae K; Kondo T; Tanabe K Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069 [TBL] [Abstract][Full Text] [Related]
18. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372 [TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis. Li DY; Hao XY; Ma TM; Dai HX; Song YS Sci Rep; 2017 Nov; 7(1):15387. PubMed ID: 29133845 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]